Search Within

Michael David Offin

  1. "Nursing"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (2)
Groups
  1. Department of Medicine (6)
  2. Nursing (6)
  3. Solid Tumor Oncology Division (6)
  4. Thoracic Oncology (6)
  5. Weinberg Fellows (6)
  6. Radiology, Department of (5)

More Groups

People
  1. Robert Young (4)
  2. Eli Diamond (3)
  3. Ryan Mitchell (3)
  4. Adrienne Boire (2)
  5. Anna Piotrowski (2)
  6. Bob Li (2)

More People

Years
  1. 2024 (3)
  2. 2023 (1)
  3. 2022 (1)
  4. 2020 (1)
Publications
  1. Annals of Oncology (1)
  2. Clinical Cancer Research (1)
  3. International Journal of Radiation Oncology, Biology, Physics (1)
  4. Journal of Clinical Oncology (1)
  5. Neuro-Oncology (1)
  6. Neuro-Oncology Advances (1)
Publishers
  1. Oxford University Press (3)
  2. American Association for Cancer Research (1)
  3. American Society of Clinical Oncology (1)
  4. Elsevier Inc. (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multi-center phase I study of concurrent paxalisib and radiation therapy in patients with solid tumor brain metastases (BM) or leptomeningeal metastases (LM) harboring PI3K pathway mutations
    Meeting Abstract

    Imber, B. S.; Kotecha, R.; Blau, M. H.; Friend, J.; Young, R. J.; Offin, M.; Michelle, R.; Diamond, E.; Yang, J. T.
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small-cell lung cancer
    Journal Article

    Choudhury, N. J.; Lai, W. V.; Makhnin, A.; Heller, G.; Eng, J.; Li, B.; Preeshagul, I.; Santini, F. C.; Offin, M.; Ng, K.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • A phase 2 study of amivantamab plus lazertinib in patients with EGFR-mutant lung cancer and active central nervous system disease
    Meeting Abstract

    Yu, H. A.; Chen, M. F.; Hui, A. B.; Choudhury, N. J.; Lee, J. J. K.; Zheng, J.; Ahn, L. S. H.; Pupo, A.; Nesselbush, M.; Jabara, I.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase I study of paxalisib and radiotherapy for CNS disease harboring PI3K pathway mutations: Pilot analysis of circulating tumor DNA for patient eligibility confirmation and post-treatment response
    Meeting Abstract

    Imber, B.; Ravichandran, V.; Rao, P.; Casanova, H.; Friend, J.; Simpson, J.; Pike, L.; Zinovoy, M.; Mitchell, R.; Chacko, C.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Phase I study of concurrent paxalisib and radiation therapy in patients with solid tumor brain metastases or leptomeningeal metastases harboring PI3K pathway mutations: Results from the dose-escalation cohort
    Meeting Abstract

    Yang, J.; Mann, J.; Pike, L.; Zinovoy, M.; Young, R.; Offin, M.; Mitchell, R.; Kazarian, A.; Shadat, T.; Garner, J.; more...
    Neuro-Oncology Advances (2022)

    Fulltext@MSK | Save
  • Characterization of on-target adverse events caused by TRK inhibitor therapy
    Journal Article

    Liu, D.; Flory, J.; Lin, A.; Offin, M.; Falcon, C. J.; Murciano-Goroff, Y. R.; Rosen, E.; Guo, R.; Basu, E.; Li, B. T.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save